MedTrace Logo

Pharmacy Implementation Trial: Adherence to Antihypertensive Therapy

NCT00460343 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2008-07-10

No results posted yet for this study

Summary

The purpose of this study is to determine the effectiveness of maximal support of community pharmacies to implement a pharmaceutical care model for establishing and - if necessary - improving adherence to antihypertensive medication in patients with medication-resistant hypertension.

Conditions

Interventions

OTHER

extensive implementation programme

experimental pharmacists follow an extensive implementation programme. They attend two interactive half a day educational meetings tailored to individual needs: one at start of the intervention, and one in May or September 2007. Special attention is given to multiprofessional cooperation with general practitioners and nurse practitioners. Additionally, guided by their own project planning pharmacists receive three or more telephone calls, both as a reminder, feedback, and in order to investigate whether they need any more help.

OTHER

control

pharmacists only receive a written manual with instructions to implement the patient compliance intervention.

Sponsors & Collaborators

  • Zorgverzekeraar CZ

    collaborator OTHER

  • Scientific Institute for Dutch Pharmacists, The Netherlands

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Peter G de Smet, PhD · Radboud University Medical Center

  • Michel Wensing, PhD · Scientific Institute for Quality of Healthcare

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2008-05-31
Completion
2008-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00460343 on ClinicalTrials.gov